Results 31 to 40 of about 29,949 (204)

Venous Thromboembolism Prophylaxis with Enoxaparin Versus Unfractionated Heparin in Patients with Low Body Weight

Plasmatology, 2023
Background Although reduced doses of enoxaparin have been studied in low body weight patients, no study has directly compared enoxaparin to unfractionated heparin for venous thromboembolism (VTE) prophylaxis in this population. Objective To determine the
David Michael Kaylor PharmD, Regan Merrell Wade PharmD, BCPS, Kathryn Brinkley Chappell PharmD, BCPS, Meredith Huff Niemann PharmD, BCPS, Vanessa Marie VanArsdale PharmD, BCPS   +4 more
doaj   +1 more source

Comparison of Intravenous Enoxaparin with Subcutaneous Enoxaparin in Preventing Venous Thromboembolism in Patients Admitted to Intensive Care Unit

Archives of Anesthesia and Critical Care, 2020
Background: The use of subcutaneous enoxaparin is a usual method for preventing venous thromboembolism (VTE) in the intensive care unit (ICU) patients, but adequate absorption of the drug is not reliable due to the illness intensity, existing edema and ...
Masoum Khoshfetrat, Majid Khorram, Aliakbar Keykha, Hossein Ansari   +3 more
doaj   +1 more source

Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction [PDF]

, 2002
Background — ENTIRE-TIMI 23 evaluated enoxaparin with full-dose tenecteplase (TNK) and half-dose TNK plus abciximab.
Hubert F. Baars, Elliott M. Antman, Eugene Braunwald, Bas Hamer, Hans W. Louwerenburg, Ghislaine Pisapia, Jean-Pierre Bassand, Hein Heidbuchel, Jan C.L. Wesdorp, Frederique Bigonzi, C. Michael Gibson, Frans Van de Werf   +11 more
core   +1 more source

Comparative efficacy and safety of anticoagulants for prevention of venous thromboembolism after hip and knee arthroplasty: A network meta-analysis

Acta Orthopaedica, 2017
Background and purpose — New oral anticoagulants have been developed to prevent venous thromboembolism (VTE) after knee or hip arthroplasty. Although there have been several network meta-analyses (NMA) to compare different regimens, an NMA including 2 ...
Min Hur, Sun-Kyung Park, Chang-Hoon Koo, Eun Dhong Jung, Pyoyoon Kang, Won Ho Kim, Jin-Tae Kim, Chul-Woo Jung, Jae-Hyon Bahk   +8 more
doaj   +1 more source

Enoxaparin-associated giant retroperitoneal hematoma in pulmonary embolism treatment [PDF]

, 2011
Context: Retroperitoneal hematoma may usually occur as a result of trauma. A life threatening retroperitoneal hematoma is not expected complication of anticoagulation treatment and rarely reported.
Tacettin Ornek, Beşir, Fahri Halit, Kart, Levent, Özer, Tülay, Fahri Besir, Mesut Gul, Örnek, Tacettin, Tulay Ozer, Gül, Mesut, Levent Kart, Uçan, Bülent, Bulent Ucan   +11 more
core   +1 more source

Comparison of pain after prophylactic anticoagulant injections to prevent venous thromboembolism

Surgery Open Science
Subcutaneous injection of unfractionated heparin (UH) or low molecular weight heparin (LMWH) is frequently utilized for venous thromboembolism chemoprophylaxis.
Margaret Shyu, Tyler P. Robinson, Allison M. Morgan, Julie K. Johnson, Ying Shan, Karl Y. Bilimoria, Anthony D. Yang   +6 more
doaj   +1 more source

Application of thromboelastography in comparing coagulation difference of rivaroxaban and enoxaparin for thromboprophylaxis after total hip arthroplasty

Journal of Orthopaedic Surgery, 2021
Purpose: The purpose of this study was to compare the coagulation difference in patients with either rivaroxaban or enoxaparin as thromboprophylaxis after total hip arthroplasty (THA) regarding thromboelastography (TEG) and routine coagulation tests ...
Chao-wen Bai, Ru-xin Ruan, Sheng Pan, Chao-ran Huang, Xing-chen Zhang, Yong Pang, Xin Zheng, Kai-jin Guo   +7 more
doaj   +1 more source

Therapeutic role of enoxaparin in intra-uterine growth restriction: A randomized clinical trial

, 2021
Objective: Intrauterine growth restriction is a leading cause of perinatal mortality and morbidity. Using enoxaparin may enhance the placental circulation and improve the intrauterine growth.
Fathi, M., Nazari, F, Sharbaf, F.R., Naeiji, Z, Golshahi, F, Shirazi, M, Sahebdel, B., Naeiji, Z., Nazari, F., Fathi, M, Golshahi, F., Shirazi, M., Sharbaf, F.R, Sahebdel, B   +13 more
core  

Double-Blind Randomized Clinical Trial to Examine the Pharmacokinetic and Clinical Impacts of Fixed Dose versus Weight-based Enoxaparin Prophylaxis: A Methodologic Description of the FIxed or Variable Enoxaparin (FIVE) Trial

Plastic and Reconstructive Surgery, Global Open, 2019
Venous thromboembolism is an important patient safety in plastic surgery, and multiple clinical trials in the past 10 years have provided increased understanding of the risks and benefits of venous thromboembolism prevention strategies.
Christopher J. Pannucci, MD, MS, Kory I. Fleming, MPH, Corinne Bertolaccini, PharmD, Ann Marie Prazak, PharmD, BCPS, Gregory J. Stoddard, MPH, Arash Momeni, MD   +5 more
doaj   +1 more source

Current practice and guideline adherence in renal dose adjustment for patients with chronic kidney disease: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims To quantify prescribing adherence to renal dosing recommendations in adults with chronic kidney disease (CKD; Stage 3 and above) and to evaluate the clinical consequences of non‐adherence. Methods This systematic review and meta‐analysis was conducted in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD42025620883).
Hager ElGeed, Ahmed Tehemar, Mohamed Gasimelseed, Ahmed Gharaibeh, Muhammad Abdul Hadi, Kazeem Yusuff, Amani Zidan, Ahmed Awaisu   +7 more
wiley   +1 more source